1. Volume 148, Issue 4, Pages 679-684 (April 2015)
TM6SF2: Catch-22 in the Fight Against Nonalcoholic Fatty Liver Disease and Cardiovascular Disease? 
Bratati Kahali 
Gastroenterology 
Volume 148, Issue 4, Pages (April 2015)
DOI: /j.gastro
Copyright © 2015 AGA Institute Terms and Conditions

2. Figure 1
Effects of TM6SF2. TM6SF2 plays a role in VLDL export from liver to serum which results in increased serum lipids and myocardial infarction, and decreased risk of liver steatosis. chol, cholesterol; LDL, low-density lipoprotein cholesterol; IHTG, intrahepatic triglyceride; NASH, nonalcoholic steatohepatitis; TG, triglyceride; VLDL, very low-density lipoprotein.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2015 AGA Institute Terms and Conditions